Patents by Inventor Torbjorn Omland

Torbjorn Omland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Granin proteins as markers of heart disease
    Patent number: 8497074
    Abstract: The present invention relates to methods for the diagnosis of impaired cardiac function/heart disease. The present invention provides a method of diagnosing heart disease in a subject, said method comprising determining the level of CgB or SgII, or fragments thereof, in a body fluid of said subject. Such methods can also be used to determine the clinical severity or prognosis of heart disease in a subject.
    Type: Grant
    Filed: October 12, 2009
    Date of Patent: July 30, 2013
    Assignee: Universitetet I Oslo
    Inventors: Helge Rosjo, Geir Christensen, Torbjorn Omland, Mats Stridsberg
  • SGII AS A PROGNOSTIC MARKER IN CONDITIONS WHICH REQUIRE CRITICAL CARE
    Publication number: 20130034499
    Abstract: The present invention relates to methods for determining the prognosis of a condition which requires critical care, said methods comprising determining the level of SgII, or fragments thereof in a subject. The methods of the invention can also be used to determine whether an individual is suffering from a condition which requires critical care and determining the severity of a condition which requires critical care.
    Type: Application
    Filed: November 15, 2010
    Publication date: February 7, 2013
    Applicant: Universitetet I Oslo
    Inventors: Helge Røsjø, Geir Christensen, Torbjørn Omland, Mats Stridsberg
  • GRANIN PROTEINS AS MARKERS OF HEART DISEASE
    Publication number: 20110223106
    Abstract: The present invention relates to methods for the diagnosis of impaired cardiac function/heart disease. The present invention provides a method of diagnosing heart disease in a subject, said method comprising determining the level of CgB or SgII, or fragments thereof, in a body fluid of said subject. Such methods can also be used to determine the clinical severity or prognosis of heart disease in a subject.
    Type: Application
    Filed: October 12, 2009
    Publication date: September 15, 2011
    Applicant: UNIVERSITETET I OSLO
    Inventors: Helge Rosjo, Geir Christensen, Torbjorn Omland, Mats Stridsberg